scholarly journals Attrition Bias in an Observational Study of Very Low‐Energy Diet: A Cohort Study

Obesity ◽  
2020 ◽  
Vol 29 (1) ◽  
pp. 213-219
Author(s):  
Deanna J. M. Isaman ◽  
William H. Herman ◽  
Amy E. Rothberg
Healthcare ◽  
2016 ◽  
Vol 4 (3) ◽  
pp. 71 ◽  
Author(s):  
Alice Gibson ◽  
Janet Franklin ◽  
Andrea Pattinson ◽  
Zilvia Cheng ◽  
Samir Samman ◽  
...  

2019 ◽  
Vol 15 (10) ◽  
pp. S114
Author(s):  
Line Kristin Johnson ◽  
Rune Sandbu ◽  
Ida Robertsen ◽  
Anders Åsberg ◽  
Tommy Andersson ◽  
...  

2013 ◽  
Vol 53 (6) ◽  
pp. 1421-1429 ◽  
Author(s):  
C. D. Simões ◽  
J. Maukonen ◽  
K. P. Scott ◽  
K. A. Virtanen ◽  
K. H. Pietiläinen ◽  
...  

BMJ ◽  
2010 ◽  
Vol 341 (jul07 2) ◽  
pp. c2701-c2701 ◽  
Author(s):  
A. J. Sinclair ◽  
M. A. Burdon ◽  
P. G. Nightingale ◽  
A. K. Ball ◽  
P. Good ◽  
...  

Obesity Facts ◽  
2010 ◽  
Vol 3 (3) ◽  
pp. 159-165 ◽  
Author(s):  
Lena Gripeteg ◽  
Jan Karlsson ◽  
Jarl Torgerson ◽  
Anna Karin Lindroos

2012 ◽  
Vol 108 (8) ◽  
pp. 1466-1474 ◽  
Author(s):  
Irene A. Munro ◽  
Manohar L. Garg

Obesity is associated with elevated levels of inflammation and metabolic abnormalities which are linked to CVD. The aim of the present study was to investigate whether long-chain n-3 PUFA (LCn-3PUFA), combined with a very-low-energy diet (VLED), facilitated weight loss and weight maintenance, and improvements in blood lipids and inflammatory mediators. This was a double-blind, randomised, controlled trial with two parallel groups. For 14 weeks, one group consumed 6 × 1 g capsules/d of monounsaturated oil (placebo group, PB), and the other group consumed 6 × 1 g capsules/d of LCn-3PUFA (fish oil group, FO), each comprising 70 mg EPA and 270 mg DHA. Both groups were on VLED for 4 weeks (n 14 PB, n 18 FO), which was then followed by 10 weeks of weight maintenance (n 12 PB, n 17 FO). Fasting blood samples, anthropometric measurements and 3 d food diaries were collected at baseline, at 4 and 14 weeks. A greater-than-2-fold increase occurred in plasma levels of EPA and DHA in the FO group (P < 0·001). At 4 weeks, the mean weight loss was − 6·54 (sd 2·08) kg ( − 6·9 %) for PB and − 6·87 (sd 1·83) kg ( − 7·7 %) for FO. At week 14, after the maintenance phase, there was a further mean decrease in weight, − 1·57 (sd 3·7) kg (1·85 %) for PB and − 1·69 (sd 2·32) kg ( − 1·9 %) for FO. Both groups experienced improved metabolic profiles and there was a significant reduction in fat mass for the FO group at week 14 but not for PB. However, it would appear that supplementation with LCn-3PUFA had no significant effect on weight loss or weight maintenance over the 14 weeks.


Sign in / Sign up

Export Citation Format

Share Document